Wolfgang Hofmann, a pharma industry veteran and entrepreneur, has been named as chief executive officer of leon-nanodrugs GmbH to lead the German company towards bringing its technology for nano-encapsulation devices and equipment portfolio to the market. leon-nanodrugs develops devices for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles. Dr Hofmann brings 30 years’ experience in medicine, medical research and corporate strategy. He contributed to early gene therapy systems at the Dana-Farber Cancer Institute and Harvard Medical School, US, and later held senior positions at Novartis and Fresenius Group.
Copyright 2025 Evernow Publishing